Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solid Tumors Harboring a BRAF V600 Mutation × encorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 4 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Solid Tumors Harboring a BRAF V600 Mutation 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Disease Progression 1 Digestive System Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

ribociclib 1 encorafenib 1 binimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01543698 2024-03-13

A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors

Pfizer

Phase 1/2 Completed

189 enrolled 44 charts

Other solid neoplasm

Solid Tumors Harboring a BRAF V600 Mutation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡